- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.49 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x GJ0: (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid(Non-covalent)
- 3 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
9Z9.2: 17 residues within 4Å:- Chain A: L.96, I.97, S.100, L.101, G.104, L.108, D.109, M.121, V.392, I.396, L.434, V.437, G.438, S.441, I.442, T.449, L.452
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.96, A:L.101, A:L.101, A:V.392, A:I.396, A:L.434, A:V.437, A:V.437, A:T.449, A:L.452
9Z9.8: 17 residues within 4Å:- Chain B: L.96, I.97, S.100, L.101, G.104, L.108, D.109, M.121, V.392, I.396, L.434, V.437, G.438, S.441, I.442, T.449, L.452
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:L.96, B:L.101, B:L.101, B:V.392, B:I.396, B:L.434, B:V.437, B:V.437, B:T.449, B:L.452
9Z9.14: 17 residues within 4Å:- Chain C: L.96, I.97, S.100, L.101, G.104, L.108, D.109, M.121, V.392, I.396, L.434, V.437, G.438, S.441, I.442, T.449, L.452
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:L.96, C:L.101, C:L.101, C:V.392, C:I.396, C:L.434, C:V.437, C:V.437, C:T.449, C:L.452
- 6 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 5 residues within 4Å:- Chain A: L.45, L.49, W.286, L.290
- Ligands: PC1.6
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.45, A:L.49, A:W.286, A:W.286, A:W.286, A:W.286, A:L.290
CLR.4: 7 residues within 4Å:- Chain A: I.325, F.345, F.348, W.355, M.477, S.480, V.481
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.325, A:F.345, A:F.348, A:F.348, A:W.355, A:V.481
- Hydrogen bonds: A:S.480
CLR.9: 5 residues within 4Å:- Chain B: L.45, L.49, W.286, L.290
- Ligands: PC1.12
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.45, B:L.49, B:W.286, B:W.286, B:W.286, B:W.286, B:L.290
CLR.10: 7 residues within 4Å:- Chain B: I.325, F.345, F.348, W.355, M.477, S.480, V.481
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:I.325, B:F.345, B:F.348, B:F.348, B:W.355, B:V.481
- Hydrogen bonds: B:S.480
CLR.15: 5 residues within 4Å:- Chain C: L.45, L.49, W.286, L.290
- Ligands: PC1.18
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:L.45, C:L.49, C:W.286, C:W.286, C:W.286, C:W.286, C:L.290
CLR.16: 7 residues within 4Å:- Chain C: I.325, F.345, F.348, W.355, M.477, S.480, V.481
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:I.325, C:F.345, C:F.348, C:F.348, C:W.355, C:V.481
- Hydrogen bonds: C:S.480
- 6 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.5: 4 residues within 4Å:- Chain A: V.133, I.137, I.425, L.430
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.133, A:I.137, A:I.425, A:L.430
PC1.6: 16 residues within 4Å:- Chain A: L.77, F.80, P.81, I.84, M.88, M.91, M.283, I.284, W.286, Y.287
- Chain B: F.176, G.247, F.248, A.251, I.254
- Ligands: CLR.3
13 PLIP interactions:9 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.77, A:F.80, A:P.81, A:P.81, A:I.84, A:I.84, A:I.284, A:I.284, A:Y.287, B:F.176, B:F.176, B:A.251, B:I.254
PC1.11: 4 residues within 4Å:- Chain B: V.133, I.137, I.425, L.430
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.133, B:I.137, B:I.425, B:L.430
PC1.12: 16 residues within 4Å:- Chain B: L.77, F.80, P.81, I.84, M.88, M.91, M.283, I.284, W.286, Y.287
- Chain C: F.176, G.247, F.248, A.251, I.254
- Ligands: CLR.9
13 PLIP interactions:9 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:L.77, B:F.80, B:P.81, B:P.81, B:I.84, B:I.84, B:I.284, B:I.284, B:Y.287, C:F.176, C:F.176, C:A.251, C:I.254
PC1.17: 4 residues within 4Å:- Chain C: V.133, I.137, I.425, L.430
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:V.133, C:I.137, C:I.425, C:L.430
PC1.18: 16 residues within 4Å:- Chain A: F.176, G.247, F.248, A.251, I.254
- Chain C: L.77, F.80, P.81, I.84, M.88, M.91, M.283, I.284, W.286, Y.287
- Ligands: CLR.15
13 PLIP interactions:9 interactions with chain C, 4 interactions with chain A- Hydrophobic interactions: C:L.77, C:F.80, C:P.81, C:P.81, C:I.84, C:I.84, C:I.284, C:I.284, C:Y.287, A:F.176, A:F.176, A:A.251, A:I.254
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kato, T. et al., Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun (2022)
- Release Date
- 2022-08-10
- Peptides
- Excitatory amino acid transporter 2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.49 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x GJ0: (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid(Non-covalent)
- 3 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
- 6 x CLR: CHOLESTEROL(Non-covalent)
- 6 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kato, T. et al., Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun (2022)
- Release Date
- 2022-08-10
- Peptides
- Excitatory amino acid transporter 2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.